FDA approves new pain medication as an alternative to opioids: What to know about Journavx
The FDA on Thursday approved a new class of pain medication that provides an alternative to opioids. It will be sold under ...
US FDA approves Vertex's non-opioid painkiller
The U.S. Food and Drug Administration has approved Vertex Pharmaceuticals' drug to treat acute pain, the health regulator ...
FDA approves Ozempic to reduce risks from chronic kidney disease in diabetes patients
Ozempic, the blockbuster GLP-1 drug that was originally approved to treat type 2 diabetes, has now also been approved by the ...
US FDA approves Novo Nordisk's Ozempic to cut risk of diabetic kidney disease progression
The U.S. FDA has approved Novo Nordisk's Ozempic for reducing the risk of kidney failure and disease progression, as well as ...
FDA Approves Ozempic to Treat Kidney Disease
The Food and Drug Administration approved Novo Nordisk’s Ozempic as the first GLP-1 treatment option for people with type 2 ...
An Unprecedented 22 Percent Drop in Drug Deaths Does Not Mean Prohibition Is Finally Working
During the year ending last August, according to preliminary estimates from the Centers for Disease Control and Prevention ...
Americans might finally have to face what’s in their food
A front-of-package food label would be a great educational tool. The Trump administration should keep it.
Cure Today3d
FDA Approves Enhertu for HER2-Low and -Ultralow Breast Cancer
The antibody drug conjugate was approved for patients with unresectable or metastatic HER2-low or -ultralow breast cancer ...
Trump Administration Halts H.I.V. Drug Distribution in Poor Countries
PEPFAR’s computer systems also are being taken offline, a sign that the program may not return, as Republican critics had ...
Trump administration withdraws proposed menthol ban
The Trump administration has withdrawn the proposed rule that would ban menthol in cigarettes and flavored cigars according ...
Yahoo Finance4d
ILiAD and hVIVO Sign LOI for Pivotal Phase 3 Trial of BPZE1 Pertussis Vaccine Following FDA Meeting
today announced that following a December 2024 Type C meeting with the United States Food and Drug Administration (FDA), ILiAD and hVIVO plc (hVIVO) have signed a Letter of Intent (LOI ...